CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Sarah M. Larson, Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha Gandhi, Thomas Schweppe, Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Martin Allen-Auerbach, Jonathan Said, Karla Nawaly, Monica Mead, Sven De Vos, Patricia Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Antoni Ribas, View ORCID ProfileYvonne Y. Chen
doi: https://doi.org/10.1101/2022.09.13.22279873
Sarah M. Larson
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Christopher M. Walthers
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Brenda Ji
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Sanaz N. Ghafouri
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
Jacob Naparstek
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
Jacqueline Trent
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
Jia Ming Chen
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
Mobina Roshandell
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Caitlin Harris
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Mobina Khericha Gandhi
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Thomas Schweppe
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Beata Berent-Maoz
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
Stanley B. Gosliner
5Department of Chemical and Biomolecular Engineering, UCLA, Los Angeles, CA, USA
Amr Almaktari
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
Martin Allen-Auerbach
6Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Jonathan Said
7Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA, USA
Karla Nawaly
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
Monica Mead
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
Sven De Vos
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Patricia Young
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
Caspian Oliai
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
Gary J. Schiller
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
John M. Timmerman
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Antoni Ribas
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA
2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
8Department of Surgery, Division of Surgical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
9Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Yvonne Y. Chen
2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
3Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA
4Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA, USA
5Department of Chemical and Biomolecular Engineering, UCLA, Los Angeles, CA, USA
- Supplemental Figures 1-5[supplements/279873_file02.pdf]
Posted September 23, 2022.
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Sarah M. Larson, Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha Gandhi, Thomas Schweppe, Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Martin Allen-Auerbach, Jonathan Said, Karla Nawaly, Monica Mead, Sven De Vos, Patricia Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Antoni Ribas, Yvonne Y. Chen
medRxiv 2022.09.13.22279873; doi: https://doi.org/10.1101/2022.09.13.22279873
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Sarah M. Larson, Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha Gandhi, Thomas Schweppe, Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Martin Allen-Auerbach, Jonathan Said, Karla Nawaly, Monica Mead, Sven De Vos, Patricia Young, Caspian Oliai, Gary J. Schiller, John M. Timmerman, Antoni Ribas, Yvonne Y. Chen
medRxiv 2022.09.13.22279873; doi: https://doi.org/10.1101/2022.09.13.22279873
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12604)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (620)
- Oncology (2218)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6819)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)